Unknown

Dataset Information

0

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies.

ABSTRACT: Currently available influenza virus vaccines have inadequate effectiveness and are reformulated annually due to viral antigenic drift. Thus, development of a vaccine that confers long-term protective immunity against antigenically distant influenza virus strains is urgently needed. The highly conserved influenza virus hemagglutinin (HA) stalk represents one of the potential targets of broadly protective/universal influenza virus vaccines. Here, we evaluate a potent broadly protective influenza virus vaccine candidate that uses nucleoside-modified and purified mRNA encoding full-length influenza virus HA formulated in lipid nanoparticles (LNPs). We demonstrate that immunization with HA mRNA-LNPs induces antibody responses against the HA stalk domain of influenza virus in mice, rabbits, and ferrets. The HA stalk-specific antibody response is associated with protection from homologous, heterologous, and heterosubtypic influenza virus infection in mice.

SUBMITTER: Pardi N 

PROVIDER: S-EPMC6105651 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Currently available influenza virus vaccines have inadequate effectiveness and are reformulated annually due to viral antigenic drift. Thus, development of a vaccine that confers long-term protective immunity against antigenically distant influenza virus strains is urgently needed. The highly conserved influenza virus hemagglutinin (HA) stalk represents one of the potential targets of broadly protective/universal influenza virus vaccines. Here, we evaluate a potent broadly protective influenza v  ...[more]

Similar Datasets

Unknown Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.
| S-EPMC3676110 | biostudies-literature
Unknown Influenza virus hemagglutinin stalk-based antibodies and vaccines.
| S-EPMC3804342 | biostudies-literature
Unknown Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.
| S-EPMC5485662 | biostudies-literature
Unknown Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
| S-EPMC7382271 | biostudies-literature
Unknown Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
| S-EPMC9772109 | biostudies-literature
Unknown Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.
| S-EPMC3966466 | biostudies-literature
Unknown Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
| S-EPMC7720065 | biostudies-literature
Unknown Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
| S-EPMC5853962 | biostudies-literature
Unknown A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
| S-EPMC7392193 | biostudies-literature
Unknown Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.
| S-EPMC3745432 | biostudies-literature